An imaging platform based on time-resolved structured light and hyperspectral single-pixel detection has been developed to perform quantitative fluorescence lifetime imaging (FLI) over a large field of view (FOV) and multiple spectral bands simultaneously. We demonstrate the potential of this new imaging platform by quantitatively imaging near-infrared FRET (Förster Resonance Energy Transfer) pair, both in vitro and in vivo. The technique is well-suited for quantitative hyperspectral lifetime imaging with high-sensitivity, paving the way for many important biomedical applications.
INTRODUCTION
Fluorescence Lifetime Imaging (FLI) offers unique contrast mechanisms in biomedical imaging that enable the functional and molecular investigation of samples from the microscopic to the macroscopic scale. FLI imaging is based on resolving the detection time of fluorescence photons emitted by native or exogenous fluorophores after temporallycontrolled light excitation. Such emission time delays can be represented by one quantity, the fluorescence lifetime, which is typically in the range of sub-to a few nanoseconds [1] . FLI aims at quantifying these lifetime values, which are fluorophore specific. The main benefits of FLI compared to traditional intensity-based imaging modalities (optical or not) is that it is not dependent on fluorophore concentration, fluorescence intensity, photo-bleaching, and/or excitation intensity [2] . Though, lifetime is an intrinsic characteristics of a fluorophore and hence can be leveraged to perform studies of multiplexed biomarker [3] . Moreover, fluorescent probes can be designed such that their lifetime is affected by microenvironmental parameters, such as temperature [4] , viscoelasticity [5] , pH value [6] , tissue oxygen level [7] , analyte concentrations and so on. Uniquely, lifetime can also be employed to monitor and quantify nanoscale interactions via Förster resonance energy transfer (FRET) imaging [8] .
FLI has found widespread biomedical utility in microscopic settings thanks to the availability of user friendly turn-key systems [1] . However, FLI is still not ubiquitous in mesoscopic [9] and macroscopic applications due to technical challenges. Chief among the challenges associated with FLI over large fields of view in biomedical applications is the lengthy acquisition time associated with the collection of dense temporal and spatial data sets, and when necessary, spectrally resolved information. One avenue to relax the constraints on the instrumental design and enable fast acquisition is to leverage the benefits of compressive sensing methodologies. We have pioneered over the last few years the development of optical imaging platforms based on structured light strategies that leverage CS methodologies [10, 11] . Our breakthrough concepts and implementations are now increasingly adopted by the biomedical optics community [12, 13, 14, 15] . Herein, we present a novel development in which we leverage a single-pixel configuration with spectrophotometric measurements to enable, for the first time, the concurrent acquisition of dense spatial, temporal, and spectral data sets in vivo at relatively fast acquisition times and with demonstration of utility in 2D and 3D imaging applications [16] (http://rdcu.be/te9i). The emission light from the sample is collected or modulated with the DMD III (D4110, Digital Light Innovations, TX) before being coupled into a PMT-(MW-FLIM, Becker and Hickl GmbH, Germany) based time-resolved spectrometer through a fiber light guide. Imaging is completed with either DMD I+III or II+III combination and optical masks can be employed in either the illumination or the detection side. The fiber light guide between DMD III and the PMT converts a 3 mm-diameter aperture into a 1 mm ×7 mm slit for spectrometer input. The dispersed light is shining on the 16 pixels on the PMT, which generate time domain data sets in 16 wavelength channels at the same time. Data acquisition is achieved with SPC-150 board (Becker and Hickl GmbH, Germany) based on the time-correlated single photon counting (TCPSC) technique and controlled over LabVIEW (NI, TX) software. To calibrate the optical masks used, an NIR CCD camera is (UI-5240CP-NIR-GL, IDS GmbH, Germany) implemented in the system (not shown in Figure 1 ).
2D imaging methodology
Implementation of compressive sensing and single pixel strategies have gained strong momentum in the biomedical optics community. These implementations are well-suited for applications requiring spectral bands in which 2D array detectors are either technically or financially unavailable. Lifetime imaging can be considered such a case since current 2D detectors have relatively low quantum efficiency, suffer from inefficient data collection scheme (gating), and are costly. Single pixel implementation for this application is not trivial and intuitively, could have affected the accurate estimation of lifetimes due to large spatial integration of the emission. Our group demonstrated early on that such integration was not detrimental to lifetime imaging and since then, lifetime-friendly single-pixel implementations have been reported for a range of applications. However, to really unleash the power of lifetime, acquisition over several spectra is preferable. Hence, we have coupled the single pixel concept with light dispersion devices for multispectral or hyperspectral data acquisition, while still retaining time-resolved capabilities. To demonstrate the potential of this approach, we have performed 2D imaging studies of FRET both in vitro and in vivo. FRET imaging enables the quantification of receptor-target engagement non-invasively [17, 18] , which is a critical parameter in designing and optimizing targeted drugs in personalized medicine [19] .
We selected the widely used Hadamard patterns [20] as optical masks-based on the assumption that the detected signal is band limited in the spatial frequency domain. Each Hadamard pattern is created by reshaping and scaling each row of the Hadamard matrix. Further, they are arranged in ascending order of absolute total difference summation of all pixels within the pattern. Considering that Hadamard matrix-based masks contain only '+1' and '-1' while optical intensity is Organs (4 h nnst-iniartinn)
positive only, we split each mask into two complementary masks with '0' and '+1' only. In this way, the orthogonality of the mask basis set is maintained and noise generated during data acquisition is suppressed [20] since the final modulated signal is the subtraction of measurements under two complementary masks. An example of in vivo spectrally resolved single-pixel acquisition is provided in Figure 2 . The single-pixel data sets were processed to yield spectrallyresolved spatial maps of both fluorescence intensity and mean lifetime (see Figure 2b and c for the spectrally resolved intensity and mean lifetime maps at 4 hours in vivo). These data are further summarized in Figure 2d and e for each organ. Donor and acceptor mean lifetime reductions were observed in the liver at both time points, in contrast to the lack of lifetime reduction in the urinary bladder. Additionally, the FD% of the two organs were computed and validated for the four subjects (Figure 3f) , and no significant difference (±6% absolute margin) was observed between the singlepixel and ICCD quantification (P = 0.007). A strong contrast between the results in the liver and the urinary bladder was observed. The liver is known to have a high density of transferrin receptor [21] and thus demonstrates a strong FRET signal. The urinary bladder, as a pathway for excretion, is not expected to be associated with such receptors, and the FRET signal was minimal despite strong fluorescence intensity. These in vivo results demonstrate that the proposed method enables quantitative investigation of in vivo fluorescence signals over the whole body of the animal even in challenging conditions such as FRET imaging (quenched donor). 
Optical Tomography (3D imaging)
Beyond implementation of the single-pixel scheme for hyperspectral FLI, structured light strategies can be leveraged to perform optical tomography [22] . As demonstrated in previous work, structured light illumination and spatial integration of CCD-based measurements enable fast and robust 3D imaging both for scattering, absorption, and fluorescence contrasts [11, 23] . Similarly, we demonstrated that our single-pixel hyperspectral time-resolved system can acquire data sets well suited to perform optical tomography of thick tissues [24] . One important aspect of this application is that biological tissues act as low pass filters. Hence, the rationale of using traditional compressive bases such as those employed for direct imaging (2D), bases that contain high frequency components, is not sustained. Indeed, if bases such as Hadamard, DCT, Wavelets, FFT-based, … have all well-defined orthogonal features prior to light propagation, the blurring associated with high-scattering leads to acquired measurements with very high redundancy. Hence, we have implemented quantized low frequency patterns that ensure optimal SNR measurements and still enable compressive acquisitions [10, 22] .
To enable the use of these spatially extended time-resolved illumination sources as well as modeling of extended detectors, we have developed in parallel a Monte Carlo platform that support the modeling of spatially complex widefields [25] with samples having complex boundaries and heterogeneous optical properties [26] . This platform is publicly available (http://mcx.space/) and allows for generation of both the forward model and the Jacobians necessary for optical tomography based on classical inverse formulations [3, 27] , CS-derived preconditioning [28] , and efficient computational implementations [29] . Additionally, to benefit from the unique features associated with time-resolved data sets, we have developed methodologies that harness the early-arriving photons, photons that have experienced less scattering, for increased spatial resolution and late photons for quantification [3] . In conjunction with inverse solvers leveraging sparsity [30, 31] , these methodologies enable millimeter resolution reconstruction in live animals.
An example of 3D reconstructions in a scattering phantom mimicking preclinical scenarios with embedded inclusions containing two fluorophore characterized by distinct lifetimes is provided in Figure 3 . Note that the time-resolved data sets enabled differentiation between the two kinds of fluorophores, conversely to the classical continuous wave (CW) data set, but better performance in quantification and reduced inter-parameter cross-talk was achieved when using the spectral dimension of our acquired 5D data cubes. Similar demonstration was performed in the context of functional imaging (retrieval of the relative material composition based on 2 spectrally distinct absorbing dyes) when using a broadband time resolved source (results not shown here).
(e) 
SUMMARY & FUTURE OUTLOOK
We have developed all the ecosystems to enable compressive lifetime imaging for biomedical applications that require sensitive multiplexed detection and large fields of view. These developments include original imaging instruments harnessing the flexibility of DMDs as well as a comprehensive suite of computational tools, from computing efficiently and accurately the forward model to solving the inverse problem. Particularly, we have recently developed a compressive hyperspectral time-resolved wide-field fluorescence lifetime imaging system that allow for capturing of dense 5D data cubes for quantitative 2D and 3D imaging of turbid tissues. Overall, in its current configuration, the system's main technical characteristics are: FOV=8x6cm2; Temporal resolution=32.6ps; IRF<170ps; 16 spectral channels with 10nm spectral resolution.
The in vivo imaging protocols that have so far been reported were conducted in ~14 minutes, and it is worth noting that acquisition times from over 10 minutes to hours are needed for the state-of-the-art commercial MFLI system, eXplore Optix, to scan a similar area of a mouse for only one wavelength [32, 33, 34] . However, the data acquisition time of our method can be considerably reduced by optimizing the spatial bases, acquiring less dense temporal data sets, temporally gating the fluorescence decay curve for enhanced SNR, or by spectral band integration. Additionally, this approach can be easily scaled in space by adapting the optics, in time by changing the TSCPC configuration, and in spectrum by adjusting the dispersive elements.
To date, we have focused on demonstrating the potential of our methodologies using a well-established CS-based approach and optimizing them for our applications. However, we also expect the imaging performance and acquisition times to be improved using contemporary approaches such as adaptive compressive techniques based on wavelet trees [35] . Similarly, we foresee that the utility of the imaging platform will be increased by implementing active wide-field strategies that dramatically improve the sensitivity of wide-field fluorescence imaging both in 2D [36, 37] and 3D applications [38] . Moreover, since the current demonstration has been performed in preclinical settings, we expect that this novel imaging methodology will greatly impact applications in the mesoscopic regime. Indeed, due to the reduced volume probed in this regime, higher-frequency as well as frequency sectioning can be performed for improved performances. Hence, applications such as imaging of bioprinted tissues [39, 40] or subcutaneous tumor xenografts [41] is expected to be performed at relatively high resolution, fast speeds, and still at millimeters depth. Last, we believe that our methodologies are well-suited for multimodal integration [42] . In this context we have initiated the fusion of our imaging platform with an advanced scattering CT imaging system [43] . The exquisite anatomical features retrieved by advanced CT systems that resolve soft-tissue contrast is expected to provide templates to guide optically-dedicated CS methods, facilitate the robust implementation of spatially guided solver, and provide an unique platform to establish deep learning-based image formation methodologies. Beyond CS-based imaging, we postulate that these DMD imaging platforms can be employed to generate phased-array sources for improved sensitivity to detect local contrast in turbid tissue [44, 45, 46] , by accessing different pulse-width modulations.
